These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2115018)
1. HIV-1 P24 antigenaemia does not predict time of survival in AIDS patients. Mulder JW; Krijnen P; Goudsmit J; Schattenkerk JK; Reiss P; Lange JM Genitourin Med; 1990 Jun; 66(3):138-41. PubMed ID: 2115018 [TBL] [Abstract][Full Text] [Related]
2. Donor HIV-1 p24 antigenaemia and course of infection in recipients Transfusion Safety Study Group. Busch MP; Donegan E; Stuart M; Mosley JW Lancet; 1990 Jun; 335(8701):1342. PubMed ID: 1971398 [No Abstract] [Full Text] [Related]
3. Predictive markers of AIDS: a follow-up of lymphocyte subsets and HIV serology in a cohort of patients with lymphadenopathy. Böttiger B; Morfeldt-Månson L; Putkonen P; Nilsson B; Julander I; Biberfeld G Scand J Infect Dis; 1989; 21(5):507-14. PubMed ID: 2511625 [TBL] [Abstract][Full Text] [Related]
4. Response of serum p24 antigen and antibody to p24 antigen in patients with AIDS and AIDS-related complex treated with zidovudine. Williams IG; Gabriel G; Kelly G; Loveday C; Tedder RS; Weller IV AIDS; 1990 Sep; 4(9):909-12. PubMed ID: 2123627 [TBL] [Abstract][Full Text] [Related]
5. Serum p24 antigen levels in untreated and zidovudine-treated HIV-1 infected subjects. Mulder JW; Lange JM; de Wolf F; Houweling JT; Bakker M; Coutinho RA; Goudsmit J Neth J Med; 1990 Aug; 37(1-2):4-10. PubMed ID: 2120599 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of HIV-1 p24 antigenemia in African and North American populations and correlation with clinical status. Brown C; Kline R; Atibu L; Francis H; Ryder R; Quinn TC AIDS; 1991 Jan; 5(1):89-92. PubMed ID: 1905553 [TBL] [Abstract][Full Text] [Related]
7. Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections. Miles SA; Wang HJ; Cortes E; Carden J; Marcus S; Mitsuyasu RT Ann Intern Med; 1990 Apr; 112(8):582-9. PubMed ID: 2109563 [TBL] [Abstract][Full Text] [Related]
8. CD4 lymphocyte counts and serum p24 antigen of no diagnostic value in monitoring HIV-infected patients with pulmonary symptoms. Orholm M; Nielsen TL; Nielsen JO; Lundgren JD AIDS; 1990 Feb; 4(2):163-6. PubMed ID: 1970256 [TBL] [Abstract][Full Text] [Related]
9. Immune activation markers and AIDS prognosis. Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808 [TBL] [Abstract][Full Text] [Related]
10. Sensitive one-step enzyme immunoassay for HIV-1 p24 antigen in human blood specimens and cell culture supernatants. Kontio S J Immunol Methods; 1991 Jun; 139(2):257-63. PubMed ID: 1904466 [TBL] [Abstract][Full Text] [Related]
11. Transient elevation of serum HIV antigen levels associated with intercurrent infection. Claydon EJ; Bennett J; Gor D; Forster SM AIDS; 1991 Jan; 5(1):113-4. PubMed ID: 1905552 [No Abstract] [Full Text] [Related]
12. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection]. Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362 [TBL] [Abstract][Full Text] [Related]
13. Surrogate markers for AIDS treatment. Jacobson M Nurs Times; 1991 May 29-Jun 4; 87(22):49. PubMed ID: 1675013 [No Abstract] [Full Text] [Related]
14. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia]. Kopecká D; Brůcková M; Stanková M; Syrůcek L; Vojtĕchovský K; Petkov V Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624 [TBL] [Abstract][Full Text] [Related]
15. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: St Stephen's Hospital experience. Stambuk D; Hawkins D; Gazzard BG J Infect; 1989 Jan; 18 Suppl 1():41-51. PubMed ID: 2492585 [TBL] [Abstract][Full Text] [Related]
16. The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex. Pedersen C; Cooper DA; Brun-Vézinet F; Doherty R; Skinhøj P; Pérol Y; Lüthy R; Leibowitch J; Habermehl KO; Varnier OE AIDS; 1992 Aug; 6(8):821-5. PubMed ID: 1418778 [TBL] [Abstract][Full Text] [Related]
17. A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals. Nishanian P; Huskins KR; Stehn S; Detels R; Fahey JL J Infect Dis; 1990 Jul; 162(1):21-8. PubMed ID: 2113075 [TBL] [Abstract][Full Text] [Related]
18. Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1. Filice G; Cereda PM; Orsolini P; Soldini L; Romero E; Rondanelli EG Microbiologica; 1990 Jul; 13(3):215-24. PubMed ID: 2125683 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of quantitative levels of HIV p24 binding capacity in HIV infection. Croxson TS; Mathur-Wagh U; Handwerger S; Siroty WE; Kaminisky D; Reagan KJ; Yancovitz SR; Mildvan D AIDS Res Hum Retroviruses; 1990 Apr; 6(4):455-63. PubMed ID: 2111160 [TBL] [Abstract][Full Text] [Related]
20. Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-alpha and zidovudine. Berglund O; Engman K; Ehrnst A; Andersson J; Lidman K; Akerlund B; Sönnerborg A; Strannegård O J Infect Dis; 1991 Apr; 163(4):710-5. PubMed ID: 1672701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]